Cantor Fitzgerald, L. P. Ac Immune Sa Transaction History
Cantor Fitzgerald, L. P.
- $8.4 Billion
- Q3 2025
Shares
3 transactions
Others Institutions Holding ACIU
# of Institutions
43Shares Held
26.8MCall Options Held
94.9KPut Options Held
22.5K-
Bvf Inc San Francisco, CA19.8MShares$65.6 Million3.24% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$8.63 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.01MShares$3.34 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny895KShares$2.96 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny770KShares$2.55 Million0.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $276M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...